Brief: BioRestorative Therapies Hosts Principal Investigator Meeting for BRTX-100 Trial
April 29 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES HOSTS PRINCIPAL INVESTIGATOR
MEETING
FOR ITS BRTX-100® PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR
DISC DISEASE
Source text for Eikon: ID:nGNX4HsTw
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM